"
Team:Pitt/simulations
From 2014.igem.org
(Difference between revisions)
| Line 22: | Line 22: | ||
<br> | <br> | ||
<div class = "link_list"> | <div class = "link_list"> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
<img src = "https://static.igem.org/mediawiki/2014/c/c7/Cathelicidin_model.png"> | <img src = "https://static.igem.org/mediawiki/2014/c/c7/Cathelicidin_model.png"> | ||
<ul> | <ul> | ||
| Line 37: | Line 31: | ||
<br> | <br> | ||
<div> | <div> | ||
| - | <a href = "https://2014.igem.org/Team:Pitt/ | + | <a href = "https://2014.igem.org/Team:Pitt/cathelicidinModels/Intro"> |
<div class = "next_page"> | <div class = "next_page"> | ||
<img src = "https://static.igem.org/mediawiki/2014/1/1b/Pitt_next_arrow.png"> | <img src = "https://static.igem.org/mediawiki/2014/1/1b/Pitt_next_arrow.png"> | ||
Latest revision as of 17:50, 17 October 2014
Simulations
The simulation section of our project consisted of two main parts:
- Explore the virtue of our cathelicidin BioBrick system as a new treatment for inflammation in acne from a systems level approach.
- Introduce a new style of computer simulations without reaction constants to iGEM in the form of Boolean network models.
